Joost van Rosmalen

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. ncbi Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing
    J van Rosmalen
    Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    BJOG 119:699-709. 2012
  2. ncbi Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review
    Mehlika Toy
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Dr, Molewaterplein 50, 3000 CA Rotterdam, The Netherlands
    BMC Infect Dis 11:337. 2011
  3. ncbi Liquid-based cervical cytology using ThinPrep technology: weighing the pros and cons in a cost-effectiveness analysis
    Esther W de Bekker-Grob
    Department of Public Health, Erasmus MC University Medical Centre Rotterdam, Rotterdam, The Netherlands
    Cancer Causes Control 23:1323-31. 2012
  4. ncbi Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study
    Matejka Rebolj
    Department of Public Health, Erasmus MC, Rotterdam, Netherlands
    BMJ 345:e6855. 2012
  5. ncbi Multicohort models in cost-effectiveness analysis: why aggregating estimates over multiple cohorts can hide useful information
    James F O'Mahony
    Department of Public Health, Erasmus MC, Erasmus University, Rotterdam, The Netherlands
    Med Decis Making 33:407-14. 2013
  6. ncbi Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model
    Inge M C M de Kok
    Erasmus MC, University Medical Center, Department of Public Health, PO Box 2040, 3000 CA Rotterdam, Netherlands
    BMJ 344:e670. 2012

Collaborators

Detail Information

Publications6

  1. ncbi Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing
    J van Rosmalen
    Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    BJOG 119:699-709. 2012
    ..To determine the most cost-effective screening programme for cervical cancer...
  2. ncbi Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review
    Mehlika Toy
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Dr, Molewaterplein 50, 3000 CA Rotterdam, The Netherlands
    BMC Infect Dis 11:337. 2011
    ..To provide a clear picture of the current hepatitis B situation, the authors performed a systematic review to estimate the age- and region-specific prevalence of chronic hepatitis B (CHB) in Turkey...
  3. ncbi Liquid-based cervical cytology using ThinPrep technology: weighing the pros and cons in a cost-effectiveness analysis
    Esther W de Bekker-Grob
    Department of Public Health, Erasmus MC University Medical Centre Rotterdam, Rotterdam, The Netherlands
    Cancer Causes Control 23:1323-31. 2012
    ..Based on the results of a Dutch randomised controlled trial, we conducted cost-effectiveness threshold analyses to investigate under what circumstances manually screened ThinPrep LBC is cost-effective for screening...
  4. ncbi Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study
    Matejka Rebolj
    Department of Public Health, Erasmus MC, Rotterdam, Netherlands
    BMJ 345:e6855. 2012
    ....
  5. ncbi Multicohort models in cost-effectiveness analysis: why aggregating estimates over multiple cohorts can hide useful information
    James F O'Mahony
    Department of Public Health, Erasmus MC, Erasmus University, Rotterdam, The Netherlands
    Med Decis Making 33:407-14. 2013
    ....
  6. ncbi Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model
    Inge M C M de Kok
    Erasmus MC, University Medical Center, Department of Public Health, PO Box 2040, 3000 CA Rotterdam, Netherlands
    BMJ 344:e670. 2012
    ....